Ditchcarbon
  • Customers
  1. Organizations
  2. Indivior
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Indivior

Company website

Indivior PLC, a global leader in addiction treatment, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2014, the company has rapidly established itself within the pharmaceutical industry, focusing on innovative solutions for opioid dependence and other substance use disorders. Indivior is renowned for its flagship product, Suboxone, which combines buprenorphine and naloxone to effectively manage opioid addiction while minimising misuse potential. This unique formulation has positioned Indivior as a key player in the market, contributing to significant advancements in addiction therapy. With a commitment to improving patient outcomes, Indivior has achieved notable milestones, including regulatory approvals and partnerships that enhance its service offerings. The company continues to lead the way in addressing the global opioid crisis, solidifying its reputation as a trusted provider in the addiction treatment sector.

DitchCarbon Score

How does Indivior's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

48

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Indivior's score of 48 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

70%

Let us know if this data was useful to you

Indivior's reported carbon emissions

In 2024, Indivior reported total global emissions of approximately 136,000,000 kg CO2e, comprising 6,986,000 kg CO2e from Scope 1, 5,174,000 kg CO2e from Scope 2 (market-based), and a significant 129,350,000 kg CO2e from Scope 3 emissions. In the UK, the company’s emissions totalled about 4,102,000 kg CO2e, with 289,000 kg CO2e from Scope 1, 368,000 kg CO2e from Scope 2 (market-based), and 3,445,000 kg CO2e from Scope 3. Comparatively, in 2023, Indivior's global emissions were about 113,000,000 kg CO2e, with Scope 1 emissions at 4,573,000 kg CO2e, Scope 2 emissions at 2,366,000 kg CO2e (market-based), and Scope 3 emissions reaching 107,779,000 kg CO2e. The UK figures for 2023 showed total emissions of approximately 6,126,000 kg CO2e, with Scope 1 at 405,000 kg CO2e, Scope 2 at 701,000 kg CO2e (market-based), and Scope 3 at 5,020,000 kg CO2e. Indivior has set ambitious climate commitments, aiming for a 100% transition to hybrid vehicles by the end of 2026, which applies to both Scope 1 and Scope 2 emissions. Additionally, the company is optimistic about achieving net-zero emissions by 2050, contingent on a globally coordinated effort towards decarbonisation. The emissions data is not cascaded from any parent organisation, and all figures are directly reported by Indivior PLC.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
699,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
2,592,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
140,000
000,000
-
0,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Indivior's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Indivior is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Indivior is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Argenx

NL
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Recipharm

SE
•
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Forest Laboratories, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Orion

FI
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250915.6
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy